Eltrombopag, a thrombopoietin- receptor agonist in the treatment of adult chronic immune thrombocytopenia: a review of the efficacy and safety profile

Por Cheng, Gregory
Publicado em 2012

Management of Chinese patients on warfarin therapy in two models of anticoagulation service – a prospective randomized trial

Por Chan, Fredric W H, Wong, Raymond S M, Lau, Wing-Hung, Chan, Thomas Y K, Cheng, Gregory, You, Joyce H S
Publicado em 2006

A mathematical model for fresh frozen plasma transfusion strategies during major trauma resuscitation with ongoing hemorrhage

Por Ho, Anthony M.H., Dion, Peter W., Cheng, Claudia A.Y., Karmakar, Manoj K., Cheng, Gregory, Peng, Zhiyong, Ng, Yu Wai
Publicado em 2005

Incidence of Deep Vein Thrombosis in Hospitalized Chinese Medical Patients and the Impact of DVT Prophylaxis

Por Cheng, Gregory, Chan, Crystal, Liu, Ying Ting, Choy, Yee Fun, Wong, Mei Mei, Yeung, Pui Kwan Ernest, Ng, Ka Ling, Tsang, Lai Shan, Wong, Raymond S. M.
Publicado em 2011

Haematological manifestations in patients with severe acute respiratory syndrome: retrospective analysis

Por Wong, Raymond S M, Wu, Alan, To, K F, Lee, Nelson, Lam, Christopher W K, Wong, C K, Chan, Paul K S, Ng, Margaret H L, Yu, L M, Hui, David S, Tam, John S, Cheng, Gregory, Sung, Joseph J Y
Publicado em 2003

Safety and prolonged activity of recombinant factor VIII Fc fusion protein in hemophilia A patients

Por Powell, Jerry S., Josephson, Neil C., Quon, Doris, Ragni, Margaret V., Cheng, Gregory, Li, Ella, Jiang, Haiyan, Li, Lian, Dumont, Jennifer A., Goyal, Jaya, Zhang, Xin, Sommer, Jurg, McCue, Justin, Barbetti, Margaret, Luk, Alvin, Pierce, Glenn F.
Publicado em 2012

Population-Wide Genetic Risk Prediction of Complex Diseases: A Pilot Feasibility Study in Macau Population for Precision Public Healthcare Planning

Por Tsui, Nancy B. Y., Cheng, Gregory, Chung, Teresa, Lam, Christopher W. K., Yee, Anita, Chung, Peter K. C., Kwan, Tsz-Ki, Ko, Elaine, He, Daihai, Wong, Wing-Tak, Lau, Johnson Y. N., Lau, Lok Ting, Fok, Manson
Publicado no Sci Rep (2018)

Recombinant factor IX-Fc fusion protein (rFIXFc) demonstrates safety and prolonged activity in a phase 1/2a study in hemophilia B patients

Por Shapiro, Amy D., Ragni, Margaret V., Valentino, Leonard A., Key, Nigel S., Josephson, Neil C., Powell, Jerry S., Cheng, Gregory, Thompson, Arthur R., Goyal, Jaya, Tubridy, Karen L., Peters, Robert T., Dumont, Jennifer A., Euwart, Donald, Li, Lian, Hallén, Bengt, Gozzi, Peter, Bitonti, Alan J., Jiang, Haiyan, Luk, Alvin, Pierce, Glenn F.
Publicado em 2012

Deep Vein Thrombosis

Publicado em 2012